INS and Hyperglycemia: The practice of using sliding scale insulin, which relies on corrective doses of insulin after hyperglycaemia, has occurred and is discouraged by professional societies because of the inherent risk of ‘insulin stacking’ and suboptimal glycaemic management [37, 38], but worryingly remains prevalent in the authors’ experience and published audits [39].